SCI Abstract

search
+
England poised to green-light precision breeding
You have full access to this article via your...
A laboratory-evolved CRISPR-associated transposase adapts to human cells
CRISPR-associated transposases (CASTs) are an attractive candidate for genome editing applications, as they enable the ins...
FDA says GM pigs safe to eat
You have full access to this article via your...
Infant receives the first customized CRISPR therapy
Base and prime editors promise to correct nearly all known pathogenic variants, but their therapeutic development is restr...
CRISPR-TO directs RNA to defined intracellular locations
Although spatial RNA organization is central to cellular functions and disease mechanisms, its functional consequences rem...
Court reignites CRISPR patent dispute
The University of California and the University of Vienna have convinced a U...
A bacterial neoantigen cancer vaccine
Neoantigen cancer vaccines hold great promise for cancer treatment but are often limited by the immunosuppressive tumor en...
First proof-of-mechanism for RNA editing in humans
The first clinical results for an RNA-editing oligonucleotide designed to correct a disease-causing single-base mutation i...
Shot in the arm for biotech fuels
The US Department of Energy (DOE) in October conditionally committed nearly $3 billion to two companies to scale up the pr...
Directed evolution of engineered virus-like particles with improved production and transduction efficiencies
Directed evolution of engineered virus-like particles with improved production and transduction efficiencies
Engineered virus-like particles (eVLPs) are promising vehicles for transient delivery of proteins and RNAs, including gene...
Author Correction: Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which...
Editor’s pick: Gate Bioscience
Editor’s pick: Gate Bioscience
Each year, Nature Biotechnology highlights companies that have received sizeable early-stage funding in the previous year....
Bezos backs taste-good lab proteins
Jeff Bezos is bankrolling two new centers to research and develop sustainable proteins that taste good and can be produced...
Precise and versatile genome editing with click editors
Precise and versatile genome editing with click editors
We developed click editors, comprising HUH endonucleases, DNA-dependent DNA polymerases and CRISPR–Cas9 nickases, wh...
Editor’s pick: Indapta Therapeutics
Editor’s pick: Indapta Therapeutics
Each year, Nature Biotechnology highlights companies that have received sizeable early-stage funding in the previous year....
Click editing enables programmable genome writing using DNA polymerases and HUH endonucleases
Click editing enables programmable genome writing using DNA polymerases and HUH endonucleases
Genome editing technologies based on DNA-dependent polymerases (DDPs) could offer several benefits compared with other typ...
Author Correction: Quantifying bias introduced by sample collection in relative and absolute microbiome measurements
In the original published version of this article, there was a 10-fold error in the 16S rRNA gene standard curves. This wa...
Large-scale discovery of chromatin dysregulation induced by oncofusions and other protein-coding variants
Large-scale discovery of chromatin dysregulation induced by oncofusions and other protein-coding variants
Population-scale databases have expanded to millions of protein-coding variants, yet insight into their mechanistic conseq...
A mini-colon models colon cancer and its microenvironment
A mini-colon models colon cancer and its microenvironment
A mini-colon device mimics colorectal tumors and their interactions with neighboring healthy tissue, stromal cells and imm...
Supercharging T cell therapy with cancer mutations
T cell therapies are still hindered by poor T cell persistence and function, making them largely ineffective against solid...
US bill targets Chinese biotechs
The United States is seeking to prevent four Chinese biotech companies from doing business in the country, citing them as ...
A retrotransposon for site-specific gene transfer
A retrotransposon for site-specific gene transfer
An engineered retrotransposon achieves targeted gene transfer into the human genome.
Making genome editing a success story in Africa
Making genome editing a success story in Africa
Mistrust surrounding genetic engineering — fed by ethical concerns, fears of unintended consequences and a lack of transpa...
Starfysh integrates spatial transcriptomic and histologic data to reveal heterogeneous tumor–immune hubs
Starfysh integrates spatial transcriptomic and histologic data to reveal heterogeneous tumor–immune hubs
Spatially resolved gene expression profiling provides insight into tissue organization and cell–cell crosstalk; howe...
De novo and somatic structural variant discovery with SVision-pro
De novo and somatic structural variant discovery with SVision-pro
Long-read-based de novo and somatic structural variant (SV) discovery remains challenging, necessitating genomic compariso...
Branched chemically modified poly(A) tails enhance the translation capacity of mRNA
Branched chemically modified poly(A) tails enhance the translation capacity of mRNA
Although messenger RNA (mRNA) has proved effective as a vaccine, its potential as a general therapeutic modality is limite...
Author Correction: Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors
Department Immunology, Memorial Sloan-Kettering Cancer Center, New York, New York, USAJohannes L. Zakrzewski, David Suh, O...
A monomeric StayGold fluorescent protein
A monomeric StayGold fluorescent protein
StayGold is an exceptionally bright and stable fluorescent protein that is highly resistant to photobleaching. Despite fav...
From AI to the Y chromosome (and everything in between)
Nature Biotechnology editors pick their favorite research articles from 2023.
Nature Biotechnology’s academic spinouts 2022
Nature Biotechnology’s academic spinouts 2022
Nature Biotechnology’s annual survey highlights academic start ups that are, among other things, correcting misfolde...
Load More
format_indent_increase